Cinchonanium, 10,11-Dihydro-9-(2-Propen-1-Yloxy)-1-[(2,3,4-Trifluorophenyl)Methyl]-, Bromide (1:1), (8α,9R)

[479617-92-0] C29H32BrF3N2O (MW 561.48) InChI = 1S/C29H32F3N2O.BrH/c1-3-15-35-29(23-11-13-33-25-8-6-5-7-22(23)25)26-16-20-12-14-34(26,17-19(20)4-2)18-21-9-10-24(30)28(32)27(21)31;/h3,5-11,13,19-20,26,29H,1,4,12,14-18H2,2H3;1H/q+1;/p-1/t19-,20-,26-,29+,34+;/m0./s1 InChIKey = VJLFGBJWARDMOE-MCVICMBESA-M (reagent used as asymmetric phase-transfer catalyst for a range of transformations) Physical Data: mp 152 °C, [α]D23 −113 (c 1.05, CHCl3). Solubility: sparingly soluble in water and most organic solvents. Form Supplied in: light yellow solid. Purification: diluted in water and methylene chloride, organic layer dried with sodium sulfate, filtered, concentrated, and recrystallized from methylene chloride/hexanes. Handling, Storage, and Precautions: store the light yellow light-sensitive solid in a darkened bottle under nitrogen. Avoid contact with skin, eye, and respiratory system. Material is not compatible with strong acids, bases, oxidizing, or reducing agents. Toxicity levels have not been determined. Quaternary ammonium salts in general possess significant biological activities: antibiotic, cytotoxicity, neurotransmitter disruption, and anaphylactic shock promotion.